Researchers at George Washington University hope to develop a vaccine to prevent an infection that is afflicting more than half a billion people around the world. “This is one of the neglected tropical diseases that has the highest impact on health globally,” said David Diemert, an associate professor of microbiology, immunology and tropical medicine, who has been working with colleagues for more than a decade hoping to eradicate the effects of the hookworm parasite. Take a look at the article for more information on why you should participate in the study.
GW seeks volunteers to let parasitic worms burrow into their skin. Any takers?
Latest News
The GW VRU is pleased to share the findings from a Phase 2 clinical trial that evaluated the effects of omicron-based COVID-19 vaccines in providing an increased level of protection against COVID-19 infection. This study adds to the evidence that matching COVID-19 vaccines to the circulating…
A protective HIV vaccine will need to induce broadly neutralizing antibodies (bnAbs) in humans, but priming rare bnAb precursor B cells has been challenging. This study provides proof-of-concept for Env trimer-based GT approaches to activate bnAb precursors and induce affinity maturation on the…
The GW VRU participated in IAVI-G002 as a clinical site for a phase 1 human clinical trial. This study evaluated the safety and immunogenicity of mRNA-encoded nanoparticles as priming immunogens and first-boosting immunogens (IAVI-G002).